You are currently viewing a new version of our website. To view the old version click .

Targeting Human Glioblastoma Stem-Like Cells (GSCs)

This special issue belongs to the section “Cancer Therapy“.

Special Issue Information

Dear Colleagues,

Glioblastoma remains a virtually incurable disease with a dismal prognosis for patients and a plethora of open questions. The current standard therapy consists of surgery, radiochemotherapy and, in some cases, the application of tumor-treating fields. Even though promising new therapeutic avenues are underway, novel and especially directed approaches are direly needed. In particular, much research in recent years showed that GBM cells can obtain a highly plastic and dynamic phenotype, which gives these cells a stem-like state that enables them to out-live conventional therapies and ultimately replenish the tumor. In order to collectively present and aggregate recent developments in precision oncology, we invite both original research and review articles highlighting key aspects of glioblastoma biology, with a special focus on stem-like cells.

Dr. Benedikt Linder
Dr. Ander Matheu
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • brain cancer
  • glioblastoma
  • glioma
  • precision medicine
  • stem-like cells
  • treatment resistance
  • tumor recurrence
  • targeted therapy
  • precision oncology

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Published Papers

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Cancers - ISSN 2072-6694